Phase 2 Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with extensive-stage small cell lung cancer (a type of lung cancer that has spread), confirmed through a tissue or cell sample.
- People who have not yet received any systemic (whole-body) treatment for this type of lung cancer.
- People who have at least one tumour that can be measured on scans, according to standard measurement guidelines.
- People aged between 18 and 75 years.
- People who are generally able to carry out daily activities with little or no limitation, as measured by a standard health scoring tool (confirm with trial site).
- People whose liver, kidneys, and other organs are functioning well enough to meet the trial's requirements (confirm with trial site).
Who may not be able to join:
- People who have cancer that has spread to the brain or spinal cord and has not been treated or is not currently stable (people with treated and stable brain metastases may still be considered).
- People who have had a serious allergic reaction to antibody-based medicines in the past.
- People who have an autoimmune disease (where the immune system attacks the body) that has required ongoing medical treatment within the last 2 years.
- People who have serious heart or blood vessel disease.
- People who currently have active hepatitis B, hepatitis C, or HIV infection.
- People who have a lung condition involving scarring or inflammation of lung tissue that is not caused by infection.
- People who have a significant risk of bleeding, including cases where the tumour is growing into major blood vessels.
- People who are currently pregnant or breastfeeding.
- People who have had another active cancer in the 5 years before joining the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-18116403289
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR); Incidence of Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.